Global Chemiluminescence Immunoassay (CLIA) Market Size, Share, Forecast Report, 2020-2027

The global Chemiluminescence Immunoassay (CLIA) market garnered revenue around USD 5.05 Billion in 2019 and projected to reach USD 8.70 Billion in 2027, with at a compound annual growth rate (CAGR) 6.4% throughout the estimate period from 2020 to 2027.

The world is currently experiencing the pandemic of an infectious disease called COVID-19. This is leading to increase in demand for the point of care tests and central laboratory tests helps in the development of varied tools including chemiluminescence immunoassay analyzers

The chemiluminescence immunoassay (CLIA) analyzers market is currently a booming one, since there has been surge in demand for laboratory automation and consolidation to improve precision and efficiency. Factors such as large sample processing capacity, large parameters testing in short period of time, high throughput, minimum labor requirement, integrated quality control & data storage, and integrated quality control and validation facility with an objective to improve overall efficacy and precision of tests with reduced turnover and incubation times is likely to drive the market during the forecast period

North America dominate the global chemiluminescence immunoassay (CLIA) analyzers market in 2018 and the trend is anticipated to continue during the forecast period. Significant average selling prices of automated chemiluminescence immunoassay analyzers, rising demand from surgeons for technologically advanced diagnostic instruments with enhanced specificity and precision, and favorable coverage as per the Clinical Laboratory Improvement Amendments for in-vitro diagnostic procedures are the factors anticipated to drive the growth of market

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Chemiluminescence Immunoassay (CLIA) market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Chemiluminescence Immunoassay (CLIA) market growth.

The global Chemiluminescence Immunoassay (CLIA) market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

 Key players in the global chemiluminescence immunoassay (CLIA) analyzers market include Abbott, F. Hoffmann-La Roche Ltd,  Siemens Healthineers (Siemens AG), Danaher (Beckman Coulter, Inc.), DiaSorin S.p.A, Ortho Clinical Diagnostics (Part of Carlyle Group), Shenzhen New Industries Biomedical Engineering Co., Ltd., Sysmex Corporation, Randox Laboratories Ltd. and Tosoh Corporation

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Global Chemiluminescence Immunoassay (CLIA) Analyzers Market, by Product

• Analyzers
  • Fully automated
  • Semi-automated
• Reagents
  • Luminophore Markers
  • Enzymatic Markers
• Consumables 

Global Chemiluminescence Immunoassay (CLIA) Analyzers Market, by Application

• Endocrine Disorders
• Oncology
• Infectious Diseases
• Hepatitis and Retrovirus
• Cardiovascular Disorders
• Allergy
• Autoimmunity
• Drug Discovery & Development
• Others 

Global Chemiluminescence Immunoassay (CLIA) Analyzers Market, by End-user

• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Industries
• Others

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Rest of EU
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
• Central & South America
  • Brazil
  • Argentina
  • Rest of Central & South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Rest of MEA